NCT00187655View on ClinicalTrials.gov

Effect of, OAT3, on the Renal Secretion of Cefotaxime

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2013

Conditions
Focus Groups
Interventions
DRUG

Cefotaxime

Cefotaxime will be administered as a single IV push of 2 grams over 5 minutes.

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT00187655 - Effect of, OAT3, on the Renal Secretion of Cefotaxime | Biotech Hunter | Biotech Hunter